Quality circles physicians-pharmacists: A local primary care network effective to maintain the costs and to improve the quality of medical prescriptions;Les cercles de qualité médecins-pharmaciens: Un réseau local reconnu pour maîtriser les coûts et la qualité de la prescription médicale

Medecine et Hygiene

Volumn 62, Issue 2501, 2004, Pages 2054-2058

  Bugnon, Olivier ^a   Niquille, Anne ^a   Repond, Christian ^b   Curty, Christian ^c   Nyffeler, Richard ^d,e  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b Societe Pharmaciens Canton Fribourg   (Switzerland)

^c Groupe Mutuel Assurances   (Switzerland)

^d Medecine Generale FMH

^e Societe de Med du Canton Fribourg   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; NEUROLEPTIC AGENT; PROTON PUMP INHIBITOR;

CONTINUING EDUCATION; COST CONTROL; DRUG COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; SWITZERLAND;

EID: 7444240993     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. La rédaction Prescrire. Cercles de qualité: des médecins et des pharmaciens ouvrent la voie. La Revue Prescrire 2000; 20: 146-8.
2. La rédaction Essential Drugs Monitor. Swiss Quality Circles: improving health care, reducing costs. Essential Drugs Monitor 2001; 30: 22.
3. Bugnon O, Gremaud-Tinguely I, Repond C, et al. Increase of generics prescriptions by physicians involved with pharmacists in quality circles. FIP Congress Proceedings, 2000, Vienna.
4. Ruggli M, Nyffeler R, Duay B, Repond C, Buchmann M, Bugnon O. Efficiency improvement of primary care prescription by cooperating in quality circles physicians-pharmacists. FIP Congress Proceedings, 2004, New-Orleans.
5. Bugnon O. Etude 2000-2002 de l'impact pharmaco-économique des cercles de qualité fribourgeois. Rapport interne à l'intention de la Commission de gestion des cercles de qualité. Société suisse des pharmaciens (SSPh), 2004.
6. Kocken GA. Medication discussion groups in the Netherlands: Five years of experience. Med Educ 1999; 33: 390-3.
7. Lassen LC, Kristensen FB. Peer comparison feedback to achieve rational and economical drug therapy in general practice: A controlled intervention study. Scand J Prim Health Care 1992; 10: 76-80.
8. Von Ferber L, Bausch J, Koster I, Schuhen I, Ihle P. Pharmacotherapeutic circles. Results of an 18-month peer-review prescribing-improvement programme for general practitioners. Pharmacoeconomics 1999; 16: 273-83.
9. Schubert I, Koster, Ihle P, von Ferber L. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: Data from the pharmacotherapeutic quality circles in Hesse, Germany. Int J Clin Pharmacol Ther 2001; 39: 492-8.
10. Lundborg CS, Wahlstrom R, Diwan VK, Oke T, Martenson D, Tomson G. Combining feedback from simulated cases and prescribing. Design and implementation of an educational intervention in primary care in Sweden. Int J Technol Assess Health Care 1999; 15: 458-72.
11. Lagerlov P, Loeb M, Andrew M, Hjortdahl P. Improving doctors' prescribing behaviour through reflection on guidelines and prescription feedback: A randomised controlled study. Qual Health Care 2000; 9: 159-65.
12. Ashworth M, Armstrong D, Lloyd D, Colwill S. The effects on GP prescribing of joining a commissioning group. J Clin Pharm Ther 2002; 27: 221-8.
13. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; 2: CD000409.